| 12018043 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +8 more |
2024-06-25 |
|
| 11807658 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +7 more |
2023-11-07 |
$8,915,000 |
| 11576922 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Erica L. Jackson, Qiuping YE +1 more |
2023-02-14 |
$6,031,000 |
| 11530236 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +8 more |
2022-12-20 |
$3,840,000 |
| 11407721 |
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Hilary Plake Beck, Michael R. DeGraffenreid, Brian M. Fox, Felix Gonzalez Lopez De Turiso +7 more |
2022-08-09 |
$237,532,000 |
| 11377469 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Erica L. Jackson, Qiuping YE +2 more |
2022-07-05 |
$4,616,000 |
| 11325938 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +7 more |
2022-05-10 |
$2,448,000 |
| 11274105 |
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists |
Gwenaella Rescourio, Ana Z. Gonzalez Buenrostro, Sean P. Brown, Mike Lizarzaburu, Julio C. Medina +5 more |
2022-03-15 |
$208,847,000 |
| 11208432 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +5 more |
2021-12-28 |
$12,042,000 |
| 11129841 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Erica L. Jackson, Qiuping YE +1 more |
2021-09-28 |
$7,578,000 |
| 11130778 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +8 more |
2021-09-28 |
$7,578,000 |
| 11124537 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +5 more |
2021-09-21 |
$16,531,000 |
| 11110103 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +5 more |
2021-09-07 |
$16,438,000 |
| 11028120 |
CD73 inhibitors |
Xiaohui Du, John Eksterowicz, Valeria R. FANTIN, Qiuping YE, Jared MOORE +8 more |
2021-06-08 |
$14,068,000 |
| 10836789 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +5 more |
2020-11-17 |
$17,084,000 |
| 10723759 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +5 more |
2020-07-28 |
$12,555,000 |
| 10472387 |
Inhibitors of glucocorticoid receptor |
Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew +2 more |
2019-11-12 |
|
| 9593129 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2017-03-14 |
$585,925,000 |
| 9376425 |
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors, Jeffrey Deignan +25 more |
2016-06-28 |
$131,915,000 |
| 9296736 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2016-03-29 |
$89,902,000 |
| 8772296 |
Benzamide derivatives and uses related thereto |
Jay P. Powers, Michael R. DeGraffenreid, Lisa Julian, Jacob Kaizerman, Dustin McMinn +4 more |
2014-07-08 |
$117,483,000 |
| 8765788 |
Tricyclic inhibitors of hydroxysteroid dehydrogenases |
Jay P. Powers, Xuelei Yan, Lisa Julian, Felix Gonzalez Lopez De Turiso |
2014-07-01 |
$165,638,000 |
| 8637576 |
Benzamide derivatives and uses related thereto |
Jay P. Powers, Michael R. DeGraffenreid, Xiao He, Lisa Julian, Dustin McMinn +2 more |
2014-01-28 |
$269,215,000 |
| 8138190 |
Diaza heterocyclic amide compounds and their uses |
Jay P. Powers, Xuelei Yan |
2012-03-20 |
$251,398,000 |
| 8076376 |
Aniline sulfonamide derivatives and their uses |
Jay P. Powers, Xiao He, Dustin McMinn, Yosup Rew |
2011-12-13 |
|